Future Retirement Success
  • Politics
  • Business
  • Investing
  • Stocks
  • Politics
  • Business
  • Investing
  • Stocks

Future Retirement Success

Politics

FDA phasing out some animal testing in ‘win-win’ for ethics and public health: commissioner

by April 10, 2025
April 10, 2025

— The Food and Drug Administration is phasing out an animal testing requirement for antibody therapies and other drugs in favor of testing on materials that mimic human organs, the FDA announced on Thursday. 

‘For too long, drug manufacturers have performed additional animal testing of drugs that have data in broad human use internationally. This initiative marks a paradigm shift in drug evaluation and holds promise to accelerate cures and meaningful treatments for Americans while reducing animal use,’ FDA Commissioner Martin A. Makary, said in comment provided to Fox News Digital. 

 ‘By leveraging AI-based computational modeling, human organ model-based lab testing, and real-world human data, we can get safer treatments to patients faster and more reliably, while also reducing R&D costs and drug prices. It is a win-win for public health and ethics.’ 

The phase-out focuses on ending animal testing in regard to researching monoclonal antibody therapies, which are lab-made proteins meant to stimulate the immune system to fight diseases such as cancer, as well as other drugs, according to the press release. 

Instead, the FDA will encourage testing on ‘organoids,’ which are artificially grown masses of cells, according to the FDA’s press release obtained by Fox Digital. 

‘The FDA will promote the use of lab-grown human ‘organoids’ and organ-on-a-chip systems that mimic human organs – such as liver, heart, and immune organs – to test drug safety. These experiments can reveal toxic effects that could easily go undetected in animals, providing a more direct window into human responses,’ the press release says. 

The FDA will also encourage the use of AI while testing drugs, including building computer modeling that can predict a drug’s behavior, Fox Digital learned. 

The phase-out will include updating its guidelines to recognize research conducted on organoids and through AI.

‘Companies that submit strong safety data from non-animal tests may receive streamlined review, as the need for certain animal studies is eliminated, which would incentivize investment in modernized testing platforms,’ the FDA explained in its press release. 

The FDA is slated to also work with fellow federal agencies, such as the National Institutes of Health, the National Toxicology Program and the Department of Veterans Affairs, to ‘accelerate the validation’ of the new testing standards and will hold a public workshop later this year to further discuss the matter. 

‘For patients, it means a more efficient pipeline for novel treatments. It also means an added margin of safety, since human-based test systems may better predict real-world outcomes. For animal welfare, it represents a major step toward ending the use of laboratory animals in drug testing. Thousands of animals, including dogs and primates, could eventually be spared each year as these new methods take root,’ Makary said. 

This post appeared first on FOX NEWS
0
FacebookTwitterGoogle +Pinterest
previous post
Mexican drug lord convicted in killing of DEA agent Enrique ‘Kiki’ Camarena is freed
next post
Musk says DOGE set to top $150B in fraud savings in FY 2026

You may also like

Uptick in dead whales along East Coast sparks...

January 26, 2023

Iran appears to have struck ship off Indian...

December 24, 2023

House quickly approves $1.7T spending bill, flees DC...

December 23, 2022

Nebraska Economic Development director resigns over COVID grant...

April 6, 2023

Bill Gates Now Shilling ‘Magic Seeds’ Made with...

September 26, 2022

Biden campaign seeks to halt slide with Black...

May 29, 2024

Publius 2.0: It Feels Like We Are Watching...

November 9, 2022

Chess Champ Gets His Butt Scanned After Being...

October 7, 2022

Tennessee ban on transgender procedures for minors can...

July 9, 2023

New GOP-backed bill would ban aid to Afghanistan...

September 23, 2024

    Get free access to all of the retirement secrets and income strategies from our experts! or Join The Exclusive Subscription Today And Get the Premium Articles Acess for Free

    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Recent Posts

    • An In Depth Conversation with Dr. Malini Saba On Leading With Impact

      May 8, 2025
    • Corporate Welfare and Low-Income Welfare

      May 8, 2025
    • Automating Asset Handovers: From Designer PDFs to Office Docs with Python

      May 8, 2025
    • Chief Justice Roberts doubles down on defense of courts as SCOTUS gears up to hear key Trump cases

      May 8, 2025
    • Trump touts ‘rebuilding and modernization’ of US air traffic control, blasts Buttigieg for having ‘no clue’

      May 8, 2025
    • Trump pulls his nomination for DC US attorney, says he’ll reveal new pick soon

      May 8, 2025

    Categories

    • Business (7,921)
    • Investing (1,941)
    • Politics (15,146)
    • Stocks (3,066)
    • About us
    • Privacy Policy
    • Terms & Conditions

    Disclaimer: futureretirementsuccess.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2025 futureretirementsuccess.com | All Rights Reserved